Perella Weinberg Partners Capital Management LP Neurocrine Biosciences Inc Transaction History

Perella Weinberg Partners Capital Management LP

  • $935 Million
  • Q1 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 05, 2020
SELL
$96.16 - $135.15 $432,720 - $608,175
-4,500 Reduced 22.73%
15,300 $1.47 Million
Q2 2020

Jul 28, 2020
SELL
$85.09 - $130.36 $51,054 - $78,216
-600 Reduced 2.94%
19,800 $2.42 Million
Q1 2020

May 12, 2020
BUY
$75.11 - $113.76 $364,283 - $551,736
4,850 Added 31.19%
20,400 $1.77 Million
Q3 2019

Nov 08, 2019
BUY
$83.82 - $101.5 $1.3 Million - $1.58 Million
15,550 New
15,550 $1.4 Million

Others Institutions Holding NBIX

# of Institutions
652
Shares Held
96.5M
Call Options Held
282K
Put Options Held
281K
View Full List

About NEUROCRINE BIOSCIENCES INC

NBIX Quotes by TradingView
  • Ticker NBIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 95,639,296
  • Market Cap $10.9B
  • Description
  • Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...
More about NBIX
Track This Portfolio

Track Perella Weinberg Partners Capital Management LP Portfolio

Follow Perella Weinberg Partners Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Perella Weinberg Partners Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Perella Weinberg Partners Capital Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email